Disclosed is a composition comprising: a.) A triptan analog selected from sumatriptan, naratriptan, eletriptan, frovatriptan, almotriptan, zolmitriptan, a salt thereof, or a combination thereof and b.) An alkylsaccharide, wherein the alkylsaccharide has an alkyl chain including between 10 to 16 carbon atoms, such as undecyl-beta-D-maltoside, dodecyl-beta-D-maltoside, tridecyl-beta-D-maltoside, tetradecyl-beta-D-maltoside, sucrose mono-dodecanoate, or a combination thereof.